Heavy Menstrual Bleeding and Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• Women only
• Adult, Older adult

Study population: Undergraduate female medical students enrolled in the Faculty of Medicine at Assiut University, Assiut, Egypt. Eligible participants are nulliparous and nulligravid female students recruited on campus during non-learning hours to complete face-to-face interviews and menstrual symptom assessments.

About this study

Official title: Prevalence of Heavy Menstrual Bleeding and Intensity of Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University

Conditions

Dysmenorrhea, Heavy Menstrual Bleeding, Menorrhagia

Keywords

WaLIDD Score, Pictorial Blood Loss Assessment Chart, PBLAC, Primary Dysmenorrhea, Menstrual Disorders, Absenteeism, Medical Students

Medical subject headings

Dysmenorrhea, Menorrhagia, Menstruation Disturbances

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Dysmenorrhea Severity Assessed by the WaLIDD Score

   Assessed using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. The instrument evaluates 4 domains: study/work ability (0 to 3), anatomical pain locations (0 to 3), pain intensity (0 to 3), and duration of pain in days (0 to 3). The total score ranges from 0 to 12 points, categorized as follows: 0 indicates no dysmenorrhea, 1 to 4 indicates mild dysmenorrhea, 5 to 7 indicates moderate dysmenorrhea, and 8 to 12 indicates severe dysmenorrhea. Higher scores reflect greater symptom severity and functional impairment.

   Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted1 Oct 2026
2. Study startOct 2026 (estimated)
3. Primary completionOct 2027 (estimated)
4. Study completionNov 2027 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for DysmenorrheaStudies of the same condition, open and under way.
• More trials run by Assiut UniversityThe sponsor's other registered studies.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.